Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)

• Autori principali: Van Damme Pierre (Autore), Gothefors Leif (Autore), Matson David O (Autore), Koch Gary (Autore), Itzler Robbin (Autore), DiNubile Mark J (Autore), Heaton Penny M (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2010-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The Rotavirus Efficacy and Safety Trial was a placebo-controlled Phase III study that evaluated the safety and efficacy of a three-dose pentavalent rotavirus vaccine (RV5) including its effect on healthcare utilization for rotavirus...